Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
12:25pm, Tuesday, 26'th Jul 2022
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Lloyds Banking, GlaxoSmithKline, US rate decision:Wednesday's agenda
11:25am, Tuesday, 26'th Jul 2022
Amid the next huge batch of corporate updates, attention Wednesday will turn towards the conclusion of the Federal Reserve's latest interest rate-setting meeting. When US inflation recently jumpe
GSK: Investors will be looking for early signs that drugs giant will hit newly issued sales and earnings targets
09:20am, Tuesday, 26'th Jul 2022
GSK PLC (LSE:GSK, NYSE:GSK)'s second-quarter figures will provide the first clues as to whether the business will flourish or founder following the £30bn demerger of its consumer business, Haleon. Re
GSK Completes Demerger of Consumer Healthcare Business
02:24pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Post demerger, GSK is set to focus on its Pharmaceuticals and Vaccines businesses. The consumer healthcare business, Haleon, will start regular-way trading on the NYSE from Jul 22.
The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Equinor, GSK and Eaton
10:05am, Tuesday, 19'th Jul 2022 Zacks Investment Research
Apple, UnitedHealth Group, Equinor, GSK and Eaton have been included in this Analyst Blog.
Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore
08:06am, Tuesday, 19'th Jul 2022 Benzinga
After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at GBX
Top Analyst Reports for Apple, UnitedHealth, Equinor & Others
08:04pm, Monday, 18'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH), and Equinor ASA (EQNR).
GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know
10:00pm, Thursday, 14'th Jul 2022 Zacks Investment Research
GlaxoSmithKline (GSK) closed at $40.22 in the latest trading session, marking a -1.71% move from the prior day.
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
03:41pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Theravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The latter also acquires Innoviva???s Trelegy royalty shares.
GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know
10:15pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
GlaxoSmithKline (GSK) closed at $40.92 in the latest trading session, marking a -1.25% move from the prior day.
How Its New Vaccine Could Propel GSK's Growth
11:00am, Monday, 11'th Jul 2022 The Motley Fool
GSK leads the race to deliver a vaccine for an untreated infectious disease.
How to Earn $10,000 a Year in Passive Retirement Income
03:00pm, Sunday, 10'th Jul 2022 The Motley Fool
You'll either need a decent chunk of change or some patience.
GlaxoSmithKline (GSK) Gains But Lags Market: What You Should Know
10:00pm, Thursday, 07'th Jul 2022 Zacks Investment Research
In the latest trading session, GlaxoSmithKline (GSK) closed at $43.32, marking a +0.49% move from the previous day.
GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know
10:15pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
In the latest trading session, GlaxoSmithKline (GSK) closed at $43.30, marking a -1.03% move from the previous day.
2 First-Rate ETFs for Stock Dividends
10:55am, Sunday, 03'rd Jul 2022 The Motley Fool
These two ETFs produce both market-beating returns and high-yielding dividends.
